1. Home
  2. BRTX vs HKPD Comparison

BRTX vs HKPD Comparison

Compare BRTX & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioRestorative Therapies Inc. (NV)

BRTX

BioRestorative Therapies Inc. (NV)

HOLD

Current Price

$2.67

Market Cap

5.4M

Sector

Health Care

ML Signal

HOLD

HKPD

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares

HOLD

Current Price

$0.13

Market Cap

6.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRTX
HKPD
Founded
1997
2016
Country
United States
Hong Kong
Employees
N/A
11
Industry
Managed Health Care
Other Pharmaceuticals
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4M
6.2M
IPO Year
2015
2024

Fundamental Metrics

Financial Performance
Metric
BRTX
HKPD
Price
$2.67
$0.13
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
274.7K
3.6M
Earning Date
05-13-2026
08-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$81,000.00
N/A
Revenue This Year
$298.39
N/A
Revenue Next Year
$64.62
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.14
$0.12
52 Week High
$4.10
$1.82

Technical Indicators

Market Signals
Indicator
BRTX
HKPD
Relative Strength Index (RSI) 63.82 20.94
Support Level $0.51 N/A
Resistance Level $4.10 $0.47
Average True Range (ATR) 0.36 0.05
MACD 0.25 -0.02
Stochastic Oscillator 65.62 3.12

Price Performance

Historical Comparison
BRTX
HKPD

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.

About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares

Cellyan Biotechnology Co Ltd is an integrated pharmaceutical cross-border e-commerce supply chain service provider with a professional team and related pharmaceutical storage facilities in Hong Kong. It operates through two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, referred to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, referred to as the Procurement and Distribution division. Its main business provides one-stop services for merchants engaged in cross-border pharmaceutical e-commerce, including OTC wholesale, import and export, warehousing, packaging, customs clearance and delivery to final destinations, forming a closed loop of pharmaceutical cross-border e-commerce supply chain.

Share on Social Networks: